Molecular basis of Pirh2-mediated p53 ubiquitylation

被引:0
|
作者
Yi Sheng
Rob C Laister
Alexander Lemak
Bin Wu
Elizabeth Tai
Shili Duan
Jonathan Lukin
Maria Sunnerhagen
Sampath Srisailam
Murthy Karra
Sam Benchimol
Cheryl H Arrowsmith
机构
[1] University of Toronto,Ontario Cancer Institute and Department of Medical Biophysics
[2] Molecular Biotechnology,Department of Biology
[3] IFM,undefined
[4] Campus Valla,undefined
[5] Linköping University,undefined
[6] York University,undefined
来源
Nature Structural & Molecular Biology | 2008年 / 15卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Pirh2 is one of several ubiquitin ligases known to modify and negatively regulate p53. Solution studies reveal the structures of the three Pirh2 domains and indicate that the C-terminal domain of Pirh2 interacts with the p53 tetramerization domain. Additional data suggest that Pirh2 preferentially modifies the tetrameric, transcriptionally active form of p53 for proteasome-mediated degradation.
引用
收藏
页码:1334 / 1342
页数:8
相关论文
共 50 条
  • [21] A molecular glue for P53
    Hai-Kun Liu
    Medicine Plus, 2024, 1 (02) : 24 - 25
  • [22] WWP2 ameliorates acute kidney injury by mediating p53 ubiquitylation and degradation
    Che, Hong
    He, Weilai
    Feng, Junbo
    Dong, Wenpeng
    Liu, Shandong
    Chen, Tao
    Ge, Shenglin
    Zhou, Jun
    Liang, Chaozhao
    CELL BIOCHEMISTRY AND FUNCTION, 2020, 38 (06) : 695 - 701
  • [23] IRTKS suppresses p53 activity through promoting MDM2 mediated p53 monoubiquitination
    Zhang, Xin
    Wang, Kesheng
    Sheng, Hailian
    Li, Tingting
    Chen, Gang
    Chen, Fei
    Wang, Qinwan
    Cheng, Zhihong
    Wang, Zhiqin
    Han, Zeguang
    CANCER RESEARCH, 2010, 70
  • [24] Molecular Basis for Modulation of the p53 Target Selectivity by KLF4
    Brandt, Tobias
    Townsley, Fiona M.
    Teufel, Daniel P.
    Freund, Stefan M. V.
    Veprintsev, Dmitry B.
    PLOS ONE, 2012, 7 (10):
  • [25] Targeting Taurine Transporter (TauT) for Cancer Immunotherapy of p53 Mutation Mediated Cancers - Molecular Basis and Preclinical Implication
    Han, Xiaobin
    TAURINE 11, 2019, 1155 : 543 - 553
  • [26] p53 mediated death of cells overexpressing MDM2 by an inhibitor of MDM2 interaction with p53
    Christine Wasylyk
    Roberto Salvi
    Manuela Argentini
    Christine Dureuil
    Isabelle Delumeau
    Joseph Abecassis
    Laurent Debussche
    Bohdan Wasylyk
    Oncogene, 1999, 18 : 1921 - 1934
  • [27] p53 mediated death of cells overexpressing MDM2 by an inhibitor of MDM2 interaction with p53
    Wasylyk, C
    Salvi, R
    Argentini, M
    Dureuil, C
    Delumeau, I
    Abecassis, J
    Debussche, L
    Wasylyk, B
    ONCOGENE, 1999, 18 (11) : 1921 - 1934
  • [28] A Stapled p53 Helix Overcomes HDMX-Mediated Suppression of p53
    Bernal, Federico
    Wade, Mark
    Godes, Marina
    Davis, Tina N.
    Whitehead, David G.
    Kung, Andrew L.
    Wahl, Geoffrey M.
    Walensky, Loren D.
    CANCER CELL, 2010, 18 (05) : 411 - 422
  • [29] Interplay between MDM2, MDMX, Pirh2 and COP1: the negative regulators of p53
    Lan Wang
    Guifen He
    Pingzhao Zhang
    Xiang Wang
    Mei Jiang
    Long Yu
    Molecular Biology Reports, 2011, 38 : 229 - 236
  • [30] The oncoprotein gankyrin binds to MDM2/HDM2, enhancing ubiquitylation and degradation of p53
    Higashitsuji, H
    Higashitsuji, H
    Itoh, K
    Sakurai, T
    Nagao, T
    Sumitomo, H
    Masuda, T
    Dawson, S
    Shimada, Y
    Mayer, RJ
    Fujita, J
    CANCER CELL, 2005, 8 (01) : 75 - 87